Ann Neale

Title: Ann Neale: Innovator in Pharmaceutical Treatments

Introduction

Ann Neale is a prominent inventor based in Danville, CA, who has made significant contributions to the field of pharmaceuticals. She is known for her innovative approaches to treating immune thrombocytopenia, a condition that affects platelet levels in the blood. With a focus on developing effective treatments, Ann has secured her place in the world of medical inventions.

Latest Patents

Ann Neale holds a patent for her work titled "Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile." This patent outlines methods for treating immune thrombocytopenia by administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof. The patent also includes pharmaceutical compositions comprising these compounds.

Career Highlights

Ann Neale is currently associated with Principia Biopharma Inc., where she continues to advance her research and development efforts. Her work has led to the creation of innovative treatments that have the potential to improve the quality of life for patients suffering from immune thrombocytopenia. With her expertise, she has become a valuable asset in the pharmaceutical industry.

Collaborations

Throughout her career, Ann has collaborated with notable professionals in her field, including Steven Gourlay and Philip Nunn. These collaborations have fostered an environment of innovation and have contributed to the success of her projects.

Conclusion

Ann Neale's contributions to the field of pharmaceuticals, particularly in the treatment of immune thrombocytopenia, highlight her role as an influential inventor. Her dedication to developing effective medical solutions continues to make